How Specialty Pharmacists Can Keep HIV Patients on ART
Originally published by our sister publication Specialty Pharmacy ContinuumBy Fran KritzA team of specialty pharmacists and pharmacy liaisons in Brooklyn successfully transitioned a small group of patients living with HIV from daily oral antiviral therapy (ART) to injectable long-acting antiretroviral therapy (LA-ART). The switch improved medication access and adherence, and optimized treatment outcomes for HIV management and PrEP, the team reported at the NASP 2025 Annual Meeting & Expo, in
Read more »